AVN 64.80 Increased By ▲ 0.63 (0.98%)
BAFL 30.90 Increased By ▲ 1.00 (3.34%)
BOP 4.73 Increased By ▲ 0.10 (2.16%)
CNERGY 3.87 Decreased By ▼ -0.02 (-0.51%)
DFML 13.44 Increased By ▲ 0.09 (0.67%)
DGKC 41.34 Increased By ▲ 0.49 (1.2%)
EPCL 46.23 Decreased By ▼ -0.77 (-1.64%)
FCCL 11.39 Increased By ▲ 0.39 (3.55%)
FFL 5.05 Decreased By ▼ -0.03 (-0.59%)
FLYNG 5.81 Increased By ▲ 0.04 (0.69%)
GGL 9.90 Increased By ▲ 0.15 (1.54%)
HUBC 64.06 Increased By ▲ 2.11 (3.41%)
HUMNL 5.67 Increased By ▲ 0.02 (0.35%)
KAPCO 27.83 Increased By ▲ 0.25 (0.91%)
KEL 2.13 Decreased By ▼ -0.02 (-0.93%)
LOTCHEM 24.35 Increased By ▲ 0.05 (0.21%)
MLCF 21.36 Increased By ▲ 0.64 (3.09%)
NETSOL 84.43 Increased By ▲ 1.33 (1.6%)
OGDC 87.80 Increased By ▲ 1.75 (2.03%)
PAEL 10.92 Increased By ▲ 0.12 (1.11%)
PIBTL 4.17 Increased By ▲ 0.03 (0.72%)
PPL 77.53 Increased By ▲ 1.34 (1.76%)
PRL 13.65 Decreased By ▼ -0.01 (-0.07%)
SILK 0.88 Decreased By ▼ -0.01 (-1.12%)
SNGP 41.75 Increased By ▲ 1.00 (2.45%)
TELE 5.89 Increased By ▲ 0.01 (0.17%)
TPLP 15.81 Increased By ▲ 0.16 (1.02%)
TRG 112.65 Increased By ▲ 2.55 (2.32%)
UNITY 13.97 Increased By ▲ 0.22 (1.6%)
WTL 1.14 Decreased By ▼ -0.01 (-0.87%)
BR100 4,048 Increased By 80.6 (2.03%)
BR30 14,467 Increased By 282.1 (1.99%)
KSE100 40,673 Increased By 801.8 (2.01%)
KSE30 15,190 Increased By 292.7 (1.96%)
Pakistan

DRAP approves Sinopharm vaccine for people above 60 years

  • NCOC states that the Sinopharm vaccine is being administered to people up to the age of 60 years, however, it would now be used to inoculate citizens above 60 years of age too
  • On February 2, the first batch of 500,000 doses of Sinopharm vaccine arrived in Pakistan as a gift from China
Published March 5, 2021
Follow us

(Karachi) The Drug Regulatory Authority of Pakistan (DRAP) has approved Sinopharm coronavirus vaccine for people above 60 years of age, local media reported on Friday.

As per the National Command and Control Centre (NCOC), the Sinopharm vaccine is being administered to people up to the age of 60 years, however, it would now be used to inoculate citizens above 60 years of age too.

DRAP has approved China’s Sinopharm coronavirus vaccine for inoculations to registered health workers over 60 years.

Earlier, Special Assistant to the Prime Minister (SAPM) on National Health Services, Dr Faisal Sultan said the Chinese made Covid-19 vaccine, Sinopharm, is not recommended for the people above 60 years of age.

He said that based on the findings of expert committee’s preliminary analysis of Sinopharm data, the government has recommended the vaccine be licensed for people aged 18-60, at this stage.

On February 2, the first batch of 500,000 doses of Sinopharm vaccine arrived in Pakistan as a gift from China to be used to inoculate the frontline health workers to protect them from COVID-19 at initial stage.

Foreign Minister Qureshi said that the vaccine had arrived right at the time when Pakistan was grappling with the second wave of COVID-19. He said that Pakistan-China cooperation in fighting the pandemic, since its outbreak, has been exemplary.

Comments

Comments are closed.

DRAP approves Sinopharm vaccine for people above 60 years

Dar meets IMF review mission, apprises it of planned power sector reforms

After 29 successive losses, rupee sees some gain, settles at 267.89 against US dollar

US Fed starts policy meeting with smaller rate hike likely

We must put our house in order, says Asif after Peshawar mosque bombing

Corps commanders resolve to bring perpetrators of Peshawar attack to ‘exemplary justice’

Inflationary pressure expected to calm down gradually: Finance Division

KSE-100 jumps 800 points owing to optimism over IMF talks

Pakistan’s performance worsens, rank remains same in corruption perception index

Barrick Gold makes first payment of $3mn to Balochistan govt

India’s Adani says to keep investing in Israel after Haifa port takeover